EVOLYRA
Live / Allowed — Notice of allowance issued (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99340190
- Mark type
- Stylized text
- Filed
- 15 Aug 2025
- Published for opposition
- 27 Jan 2026
- Attorney of record
- DAVID MACLAREN KRAMER
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy for the treatment of limb girdle muscular dystrophies
- Class 042 — Scientific and technological services: Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Gene therapy research
Owner
- Evolyra Therapeutics Inc., Glen Allen, VA, US
- Evolyra Therapeutics Inc., Glen Allen, VA, US
Prosecution history
- 24 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jan 2026 — PUBLISHED FOR OPPOSITION
- 21 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Dec 2025 — ASSIGNED TO EXAMINER
- 30 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 15 Aug 2025 — NEW APPLICATION ENTERED